Reuters logo
4 个月内
BRIEF-Akebia announces publication of phase 2A results for Vadadustat in patients with anemia related to chronic kidney disease
2017年3月28日 / 上午11点22分 / 4 个月内

BRIEF-Akebia announces publication of phase 2A results for Vadadustat in patients with anemia related to chronic kidney disease

1 分钟阅读

March 28 (Reuters) - Akebia Therapeutics Inc

* Akebia Therapeutics Inc - Akebia announces publication of phase 2A results for Vadadustat in patients with anemia related to chronic kidney disease

* Akebia Therapeutics Inc - data showed Vadadustat increased hemoglobin levels and improved iron mobilization when compared to placebo Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below